Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 7 | 2024 | 1089 | 1.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2024 | 8648 | 0.440 |
Why?
|
Prostatic Neoplasms | 6 | 2024 | 11101 | 0.360 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2024 | 454 | 0.350 |
Why?
|
Computational Biology | 2 | 2023 | 3567 | 0.340 |
Why?
|
Transcription Factors | 10 | 2024 | 12171 | 0.340 |
Why?
|
Chromatin | 6 | 2024 | 2981 | 0.320 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2024 | 724 | 0.300 |
Why?
|
Cell Line, Tumor | 16 | 2024 | 17142 | 0.290 |
Why?
|
Epigenomics | 5 | 2024 | 960 | 0.290 |
Why?
|
Phenylthiohydantoin | 3 | 2024 | 207 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2024 | 5341 | 0.250 |
Why?
|
Workflow | 2 | 2021 | 860 | 0.240 |
Why?
|
NFI Transcription Factors | 1 | 2024 | 49 | 0.240 |
Why?
|
Breast Neoplasms | 8 | 2024 | 21207 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2021 | 165 | 0.220 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1099 | 0.220 |
Why?
|
Glycocalyx | 1 | 2024 | 99 | 0.210 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 196 | 0.180 |
Why?
|
Genes, myc | 1 | 2022 | 391 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 150 | 0.180 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 253 | 0.160 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 123 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 772 | 0.150 |
Why?
|
Stromal Cells | 1 | 2024 | 1337 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2024 | 2846 | 0.150 |
Why?
|
NF-kappa B | 2 | 2024 | 2494 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 531 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 480 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 342 | 0.140 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2040 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3670 | 0.140 |
Why?
|
Software | 3 | 2023 | 4480 | 0.140 |
Why?
|
Prostate | 2 | 2022 | 1765 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 998 | 0.130 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2603 | 0.130 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9617 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 362 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.130 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1367 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13586 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 802 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 657 | 0.120 |
Why?
|
Mutation | 5 | 2024 | 30237 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 559 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1353 | 0.110 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 581 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2722 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1412 | 0.110 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5804 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1155 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2048 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1891 | 0.100 |
Why?
|
Nitriles | 3 | 2024 | 980 | 0.100 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13677 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2956 | 0.090 |
Why?
|
Benzamides | 3 | 2024 | 1379 | 0.090 |
Why?
|
Testosterone | 1 | 2022 | 2491 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1668 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1801 | 0.090 |
Why?
|
Models, Genetic | 1 | 2020 | 3447 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4786 | 0.090 |
Why?
|
RNA, Double-Stranded | 2 | 2021 | 292 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2575 | 0.080 |
Why?
|
Humans | 31 | 2024 | 768171 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3048 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2540 | 0.080 |
Why?
|
Mice | 10 | 2024 | 82049 | 0.070 |
Why?
|
Interferons | 2 | 2021 | 720 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6894 | 0.070 |
Why?
|
Animals | 13 | 2024 | 169285 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4354 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4528 | 0.060 |
Why?
|
Paclitaxel | 2 | 2023 | 1733 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6009 | 0.060 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2024 | 35 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3833 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7609 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22371 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9419 | 0.050 |
Why?
|
Male | 10 | 2024 | 364731 | 0.050 |
Why?
|
Signal Transduction | 6 | 2024 | 23648 | 0.050 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 221 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6395 | 0.050 |
Why?
|
Protein Binding | 3 | 2021 | 9343 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9118 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11930 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3612 | 0.050 |
Why?
|
Histones | 2 | 2024 | 2601 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2024 | 5797 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 328 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2024 | 1344 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2020 | 4280 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 112 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2024 | 1715 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2024 | 1105 | 0.040 |
Why?
|
Mucin-1 | 1 | 2024 | 537 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3948 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12422 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 874 | 0.040 |
Why?
|
Introns | 1 | 2021 | 965 | 0.040 |
Why?
|
Cell Survival | 2 | 2018 | 5789 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 507 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5863 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1151 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 116 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 966 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1251 | 0.040 |
Why?
|
Female | 11 | 2024 | 397187 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 710 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 96 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3445 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1760 | 0.040 |
Why?
|
DNA Methylation | 2 | 2024 | 4428 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 633 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 233 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 792 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 818 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2024 | 10478 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 854 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1752 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.030 |
Why?
|
Acetylation | 1 | 2018 | 1056 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1716 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1143 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1110 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2474 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 371 | 0.030 |
Why?
|
Immunotherapy | 2 | 2023 | 4754 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 561 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 743 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9540 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2430 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2253 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2018 | 2179 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13668 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2892 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1339 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2414 | 0.030 |
Why?
|
RNA Interference | 1 | 2021 | 2832 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2410 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2732 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2939 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2830 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3538 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1536 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3161 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2810 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1642 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4149 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4446 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2982 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5926 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4913 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9527 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4648 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15602 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11095 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3840 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12801 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22290 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 30009 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11878 | 0.010 |
Why?
|
Aged | 1 | 2018 | 171502 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 223487 | 0.000 |
Why?
|
Adult | 1 | 2018 | 223646 | 0.000 |
Why?
|